These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
693 related items for PubMed ID: 23199963
21. The Australian experience with the human papillomavirus vaccine. Garland SM. Clin Ther; 2014 Jan 01; 36(1):17-23. PubMed ID: 24417782 [Abstract] [Full Text] [Related]
22. Introduction of human papillomavirus vaccination in Nordic countries. Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Vaccine; 2012 Feb 14; 30(8):1425-33. PubMed ID: 22154773 [Abstract] [Full Text] [Related]
23. HPV vaccines: state of the art. D'Andrilli G, Bovicelli A, Giordano A. J Cell Physiol; 2010 Sep 14; 224(3):601-4. PubMed ID: 20432468 [Abstract] [Full Text] [Related]
25. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region. Jumaan AO, Ghanem S, Taher J, Braikat M, Al Awaidy S, Dbaibo GS. Vaccine; 2013 Dec 30; 31 Suppl 6():G58-64. PubMed ID: 24331821 [Abstract] [Full Text] [Related]
27. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA. Vaccine; 2013 Dec 29; 31 Suppl 5():F53-9. PubMed ID: 24331748 [Abstract] [Full Text] [Related]
28. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women? Liu X, Feng A, Cui Y, Tobe RG. Biosci Trends; 2013 Aug 29; 7(4):159-67. PubMed ID: 24056165 [Abstract] [Full Text] [Related]
29. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D. Papillomavirus Res; 2017 Dec 29; 4():72-78. PubMed ID: 29179873 [Abstract] [Full Text] [Related]
30. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer. Ault K, Reisinger K. Int J Infect Dis; 2007 Nov 29; 11 Suppl 2():S26-8. PubMed ID: 18162242 [Abstract] [Full Text] [Related]
31. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool. Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N. BMC Med; 2012 Nov 13; 10():136. PubMed ID: 23146319 [Abstract] [Full Text] [Related]
32. [Cervical cancer prevention: the impact of HPV vaccination]. Monsonégo J. Gynecol Obstet Fertil; 2006 Mar 13; 34(3):189-201. PubMed ID: 16529969 [Abstract] [Full Text] [Related]
33. Chapter 15: HPV vaccine use in the developing world. Kane MA, Sherris J, Coursaget P, Aguado T, Cutts F. Vaccine; 2006 Aug 31; 24 Suppl 3():S3/132-9. PubMed ID: 16950000 [Abstract] [Full Text] [Related]
34. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC. Clin Microbiol Infect; 2012 Oct 31; 18 Suppl 5():70-6. PubMed ID: 22882176 [Abstract] [Full Text] [Related]
38. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention]. Kohl I. Klin Mikrobiol Infekc Lek; 2006 Jun 31; 12(3):91-7. PubMed ID: 17051469 [Abstract] [Full Text] [Related]